Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with Vaccine
Ans Heirman – AVP Managing Director, MSD Switzerland
Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in…
Save
Share
IFPMA’s Thomas Cueni on why “#TeamVaccines is all of…
Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights the incredible progress of COVID-19…
Save
Share
The bright future of mRNA technology – InConversation…
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine,…
Save
Share
Russia: $7.4 bln for Healthcare Modernisation; Generics Push;…
The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…
Save
Share
Vaccines: Manufacturing & Supply Chain Complexity
Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…
Save
Share
Vaccines: An Expanded R&D Playbook
The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox in 1976 by injecting them with…
Save
Share
Brazilian Pharma: Market Outperforming LatAm, Vaccine…
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in real terms (inflation adjusted),…
Save
Share
Vaccines: Market Model Innovation
While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the pharmaceutical industry, vaccines are also…
Save
Share
France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…
Save
Share
Population Health: Access & AntiVax Challenges
Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…
Save
Share
5 Top Trends in Chinese Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning…
Save
Share
LatAm: Vaccination Challenges; Colombian COVID Variant;…
The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national COVID-19 vaccination programs, a…
Save
Share
Page: 1 |
1
2
3
4
5
6
7
8
9
10
11
interviews
{"post_type":["article","interviews","legal_article","facts","infocus","sponsored"],"post_status":"publish","posts_per_page":12,"max_num_pages":-1,"paged":1,"meta_query":[{"key":"related","value":"Vaccine","compare":"LIKE"}]}
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT